Delivery Order SPE2DB24D2205-SPE2DB25FDYJB

Award Date 2/13/25
Potential Completion Date 2/14/25
Potential Value $22K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,819.56 firm-fixed price delivery order is for the supply of CellCept 500 mg tablets, a medication used to prevent organ rejection in transplant patients. The contract has an ultimate completion date of December 6, 2024 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite...
This federal contract award, valued at $23,322.56, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CellCept 500 mg tablets, a medication commonly used in organ transplant patients. This is a firm fixed-price delivery order contract with a completion date of January 28, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,767.79 delivery order contract is for the supply of 4566420841 CellCept 500 mg tablets. The contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award is for the delivery of CellCept 500 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The $16,742.95 firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA valued up to $999,999,999.00 through December 2025, which serves as the primary vehicle for the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $22,069.14 firm fixed-price delivery order contract is for the supply of CELLCEPT 500 MG TABLET 100S, a specialty medication. The contract has an ultimate completion date of December 31, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $42,622.47 firm fixed-price delivery order is for the supply of CELLCEPT 500 MG TABLET 500S, a pharmaceutical product, to support military healthcare programs. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a...
This federal contract award is a delivery order valued at $9,223.56, issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of CellCept 500 mg tablets, a brand name pharmaceutical product. The contract has a firm fixed price pricing type and a completion date of February 13, 2024. Amerisourcebergen Drug Corp is the prime contractor on this award, which is part of a larger indefinite delivery...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $12,984.72 firm fixed-price contract is for the supply of CELLCEPT 500 MG TABLET 100S to support military healthcare programs. The contract has an ultimate completion date of January 7, 2025. The award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,931.01 firm fixed-price delivery order is for the supply of 4,566,481,699 units of CELLCEPT 500 MG TABLET 100S, with an ultimate completion date of November 20, 2024. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies in the world. The contract, valued at $9,377.75, is for the delivery of 4564312523 - CELLCEPT 500 MG TABLET 100S, a prescription medication. This is a delivery order contract with a firm fixed price pricing type. The contract has an ultimate completion date of April...
  • SPE2DB24D2205
    Indefinite Delivery Contract
  • SPE2DB24D2205-SPE2DB25FDYJB
    Delivery Order

This federal contract award, valued at $21,787.10, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026.

The contract covers the supply of CellCept 500 mg tablets, a medication used to prevent organ rejection in transplant patients. This award does not have a set-aside designation, indicating open competition. As a key vendor for federal healthcare programs, particularly within military and veterans' healthcare systems, Amerisourcebergen leverages its extensive supply chain and distribution capabilities to provide a comprehensive range of pharmaceutical products and medical supplies to support the medical needs of military personnel, veterans, and other federal beneficiaries.

Generated 5/22/25, 8:33 PM